SCHEMBL1764071

SCHEMBL1764071

O=C(NC(c1ccccc1)[PH](=O)O)OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CTRB1 P17538 2/20 0.52
ALDH1A1 P00352 4/20 0.52
CYP1A2 P05177 3/20 0.52
CTSL P07711 1/20 0.52
CTSS P25774 1/20 0.52
ATM Q13315 2/20 0.50
CYP3A4 P08684 8/20 0.49
TSHR P16473 6/20 0.49
CYP2C9 P11712 3/20 0.49
CYP2C19 P33261 3/20 0.49
CASP1 P29466 2/20 0.49
POLB P06746 1/20 0.49
CYP2D6 P10635 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
LMNA P02545 1/20 0.48
PPARG P37231 1/20 0.47
KLK1 P06870 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7719888 1.00 CTRB1 (0.52) CTRB1ALDH1A1CYP1A2CTSLCTSS
SCHEMBL1764220 0.86 CTRB1 (0.48) CTRB1ALDH1A1CYP1A2CTSLCTSS
SCHEMBL1764214 0.86 CTRB1 (0.48) CTRB1ALDH1A1CYP1A2CTSLCTSS
SCHEMBL6926649 0.81 ATM (0.57) CTRB1CTSLCTSSATM
SCHEMBL1764625 0.81 ATM (0.57) CTRB1CTSLCTSSATM
SCHEMBL3864222 0.79 CTRB1 (0.59) CTRB1ALDH1A1CTSLCTSSATM
SCHEMBL3893048 0.79 CTRB1 (0.59) CTRB1ALDH1A1CTSLCTSSATM
SCHEMBL13866599 0.79 CTRB1 (0.59) CTRB1ALDH1A1CTSLCTSSATM
SCHEMBL7759900 0.78 CTRB1 (0.57) CTRB1ALDH1A1CYP1A2CTSLCTSS
SCHEMBL5075352 0.78 ATM (0.54) CTRB1CTSLCTSSATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10131681-B2 Aminophosphinic derivatives that can be used in the treatment of pain PHARMALEADS (FR) 2018-11-20 US disclosed
US-20140161839-A1 AMINOPHOSPHINIC DERIVATIVES THAT CAN BE USED IN THE TREATMENT OF PAIN PHARMALEADS (FR) 2014-06-12 US disclosed
US-8703747-B2 Aminophosphinic derivatives that can be used in the treatment of pain PHARMALEADS (FR) 2014-04-22 US disclosed
US-20110124601-A1 AMINOPHOSPHINIC DERIVATIVES THAT CAN BE USED IN THE TREATMENT OF PAIN PHARMALEADS 2011-05-26 US disclosed
US-6518260-B1 (α-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2003-02-11 US disclosed
US-6391866-B1 ANALGESICS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2002-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124601-A1 AMINOPHOSPHINIC DERIVATIVES THAT CAN BE USED IN THE TREATMENT OF PAIN OPRM1, HRH3, HRH4 CTRB1 2680/4885ALDH1A1 3363/4885CYP1A2 779/4885
US-10131681-B2 Aminophosphinic derivatives that can be used in the treatment of pain OPRM1, HRH3, HRH4 CTRB1 2539/4885ALDH1A1 3404/4885CYP1A2 750/4885
US-20140161839-A1 AMINOPHOSPHINIC DERIVATIVES THAT CAN BE USED IN THE TREATMENT OF PAIN OPRM1, HRH3, HRH4 CTRB1 2539/4885ALDH1A1 3404/4885CYP1A2 750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.